Sante Health Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Molecular TemplatesJul 2023SEC filinghigh confidence
BiotechAustin, US
Jason S. Kim(Executive Officer)Eric E. Poma(Executive Officer, Director)David R. Hoffmann(Director)Michael Broxson(Director)David Hirsch(Director)David Valacer(Executive Officer)
Board seatKevin LalandeKevin M. Lalande· per SEC Form D · $90.7M raise · filed Jul 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.